Page last updated: 2024-11-05

trimethoprim and Autoimmune Demyelinating Disease, Peripheral

trimethoprim has been researched along with Autoimmune Demyelinating Disease, Peripheral in 2 studies

Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kollias, GV1
Clemmons, RM1
Stetzer, ER1
Walsh, MT1
Beusse, DO1
Bahemuka, M1
Shemena, AR1
Panayiotopoulos, CP1
al-Aska, AK1
Obeid, T1
Daif, AK1

Other Studies

2 other studies available for trimethoprim and Autoimmune Demyelinating Disease, Peripheral

ArticleYear
Polyradiculoneuritis in a California sea lion.
    Journal of the American Veterinary Medical Association, 1984, Dec-01, Volume: 185, Issue:11

    Topics: Animals; Anti-Infective Agents; Caniformia; Dexamethasone; Drug Combinations; Drug Therapy, Combinat

1984
Neurological syndromes of brucellosis.
    Journal of neurology, neurosurgery, and psychiatry, 1988, Volume: 51, Issue:8

    Topics: Adult; Brucella abortus; Brucellosis; Cerebrovascular Disorders; Drug Combinations; Drug Resistance,

1988